SCHEDULE 13D/A Filed 2026-07-22 Event 2026-07-20 SEC 0001213900-26-080406 →

ORAMED PHARMACEUTICALS INC. → Nano Dimension Ltd. NNDM

Stake: — Shares: 6,879,708 Class: Ordinary Shares, par value NIS 5.00 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

10 13D/G filings on this issuer

9 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-06-30

DTC 1.87

14,196,580 shares short · -0.3% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $40K

Point72 Asset Mgmt

Other 13D/G Filings on Nano Dimension Ltd.

Filed	Form	Filer	Stake	Shares
2026-07-20	SCHEDULE 13D/A	Murchinson Ltd.	—	17,136,276	view →
2026-06-30	SCHEDULE 13D	TANG CAPITAL MANAGEMENT LLC	—	14,292,813	view →
2026-06-23	SCHEDULE 13D/A	Murchinson Ltd.	—	20,285,450	view →
2026-06-17	SCHEDULE 13D/A	ORAMED PHARMACEUTICALS INC.	7.20%	15,079,708	view →
2026-05-21	SCHEDULE 13D/A	Murchinson Ltd.	7.40%	15,550,000	view →
2023-10-27	SC	Murchinson Ltd.	—	—	view →
2023-05-02	SC	Anson Funds Management LP	—	—	view →
2023-05-02	SC	Murchinson Ltd.	—	—	view →
2021-12-14	SC	STERN YOAV	—	—	view →

Other Filings by ORAMED PHARMACEUTICALS INC.

Filed	Form	Issuer	Stake	Shares
2026-06-17	SCHEDULE 13D/A	Nano Dimension Ltd. NNDM	7.20%	15,079,708	view →
2026-05-14	SCHEDULE 13D	Lifeward Ltd. LFWD	—	1,528,221	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →